3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Alcohol Drinking
5
Prostatic Neoplasms
2
Head and Neck Neoplasms
2
Substance-Related Disorders
1
Social Isolation
1
Smoking Cessation
1
Risk-Taking
1
Pancreatic Cyst
1
Pain
1
Neoplasms
1
Mouth Neoplasms
1
Lung Neoplasms
1
Flushing
1
Fanconi Anemia
1
Esophageal Neoplasms
1
Driving Under the Influence
1
Depression
1
Colorectal Neoplasms
1
Carney Complex
1
Cardiovascular Diseases
1
Binge-Eating Disorder
1
Binge Drinking
1
Alzheimer Disease
1
Agnosia
1
Interventions
Gemcitabine
32
Cisplatin
31
durvalumab
15
pembrolizumab
14
Fluorouracil
13
Oxaliplatin
12
Leucovorin
12
Capecitabine
10
Bevacizumab
8
lenvatinib
7
Nivolumab
7
zanidatamab
4
Trastuzumab
4
S 1 (combination)
4
Paclitaxel
4
Liquid Biopsy
4
Irinotecan
4
Carboplatin
4
Albumin-Bound Paclitaxel
4
tremelimumab
3
tislelizumab
3
irinotecan sucrosofate
3
Injections
3
Folfox protocol
3
130-nm albumin-bound paclitaxel
3
toripalimab
2
pertuzumab
2
niraparib
2
ivosidenib
2
envafolimab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Biliary Tract Neoplasms
×
Ethanol
×
1 year
×
Clear all
No trials found.